At www.ValuEngine.com we show that the Medical sector 10.1% overvalued with the Medical Biomed/Genetics 11.9% overvalued. All 14 stocks in today’s table have complete ValuEngine data and have enough price data to have most value levels, risky levels and pivots.
ACADIA Pharmaceuticals Inc. (ACAD) – has been below $10 since the week of April 5, 2008.
Aeterna Zentaris (AEZS) – had an upside island between $8.82 and $12.99 between the week of Jan 7, 2012 and march 31, 2012. Otherwise the stock has been below $5.75 for at least five years.
Athersys, Inc. (ATHX) – has been below $10 for at least five years.
Cleveland BioLabs, Inc. (CBLI) – has been below $10 since the week of December 15, 2007.
CytRx Corporation (CYTR) – has been below $10 since the week of April 3, 2010.
Dendreon Corp. (DNDN) – was a $57 stock in April 2010, and has been below $10 since the week of May 19, 2012.
Discovery Laboratories Inc. (DSCO) – was a $56 stock in May 2007, and has been below $10 since the week of February 27, 2010.
InterMune Inc. (ITMN) – was a $51 stock in April 2011, and has been below $10 since the week of February 16, 2013.
Keryx Biopharmaceuticals Inc. (KERX) – has been below $10 since the week of December 8, 2007. KERX almost traded up to $10 a share on January 31, 2013.
MediciNova Inc. (MNOV) – has been below $10 since the week of April 21, 2007.
Northwest Biotherapeutics, Inc. (NWBO) – was a $117 in July 2007 and has been below $10 since the week of October 13, 2012.
Oncothyreon Inc (ONTY) – has been below $10 since the week of July 30, 2011.
StemCells Inc. (STEM) – was a $36 stock in January 2007, and has been below $10 since the week of January 29, 2011.
Transcept Pharmaceuticals, Inc. (TSPT) – was a $86 stock in June 2007, and has been below $10 since the week of May 5, 2012.
Reading the Table
OV / UN Valued – The stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine. The most undervalued stock is DNDN by 73.9%. The most overvalued stock is ACAD by 128.5%.
VE Rating – A “1-Engine” rating is a Strong Sell, a “2-Engine” rating is a Sell, a “3-Engine” rating is a Hold, a “4-Engine” rating is a Buy and a “5-Engine” rating is a Strong Buy. Twelve stocks are rated Sell, with two stocks (ATHX & NWBO) are rated Strong Sell.
Last 12-Month Return (%) – Stocks with a Red number declined by that percentage over the last twelve months. Stocks with a Black number increased by that percentage over the past twelve months! The biggest winner over the last twelve months is ACAD with a gain of 233.5%. The biggest loser was NWBO with a loss of 96.1%.
Forecast 1-Year Return – Stocks with a Red number are projected to decline by that percentage over the next twelve months. Stocks with a Black number in the Table are projected to move higher by that percentage over the next twelve months. These stocks are projected to decline by 5.4% to 33.1% (NWBO) over the next twelve months.
P/E Ratios – The twelve month trailing P/E ratios. None of these stocks have P/E ratios.
Value Level: is the price at which to enter a GTC Limit Order to buy on weakness. The letters mean; W-Weekly, M-Monthly, Q-Quarterly, S-Semiannual and A- Annual.
Pivot: A level between a value level and risky level that acts as a magnet during the time frame noted.
Risky Level: is the price at which to enter a GTC Limit Order to sell on strength.
Where to Buy and Where to Sell – A “Value Level” is a price at which buyers should add to positions on market price weakness. A “Risky Level” is a price at which sellers should reduce holdings on market price gains. A “Pivot” is a support or resistance (Value Level or Risky Level) that was violated in its time horizon, acting as a magnet during the remainder of that time horizon. These levels are calculated in weekly (W), monthly (M), quarterly (Q), semiannual (S) and annual (A) time horizons, based on the past nine closes in each time horizon. My theory is that the closes over a nine-year period are the summation of all bullish and bearish events for that market or specific stock. These levels are the most important element of my Buy and Trade Strategy.
Buy and Trade Guidelines: Investors should consider entering good until cancelled (GTC) orders to buy weakness to a value level, or to sell strength to a risky level.
If you have any questions, please contact me at [email protected].